FIG. 5.
Concentrations of GSK501015 in sera from HIV-infected hCD4/hCCR5 transgenic rats. Blood samples were taken at the indicated time points relative to the morning dose administration, and GSK501015 concentrations were determined by liquid chromatography-tandem mass spectrometry. The dotted line indicates the in vitro PA-EC50 as an informative reference. p.i., postinfection.
